Mon - Fri 8:00 - 6:30

FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

HALO NEWSLETTER

Keep reading HALO with a Free Subscription

unlock this story instantly and join members and pros reading HALO daily -It's Free

Leave A Reply